Literature DB >> 35634495

SIRT1-SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms.

Wenxiu Qi1, Cheng Hu2, Daqing Zhao1, Xiangyan Li1.   

Abstract

Diabetic kidney disease (DKD) is a severe microvascular complication in patients with diabetes and is one of the main causes of renal failure. The current clinical treatment methods for DKD are not completely effective, and further exploration of the molecular mechanisms underlying the pathology of DKD is necessary to improve and promote the treatment strategy. Sirtuins are class III histone deacetylases, which play an important role in many biological functions, including DNA repair, apoptosis, cell cycle, oxidative stress, mitochondrial function, energy metabolism, lifespan, and aging. In the last decade, research on sirtuins and DKD has gained increasing attention, and it is important to summarize the relationship between DKD and sirtuins to increase the awareness of DKD and improve the cure rates. We have found that miRNAs, lncRNAs, compounds, or drugs that up-regulate the activity and expression of sirtuins play protective roles in renal function. Therefore, in this review, we summarize the biological functions, molecular targets, mechanisms, and signaling pathways of SIRT1-SIRT7 in DKD models. Existing research has shown that sirtuins have the potential as effective targets for the clinical treatment of DKD. This review aims to lay a solid foundation for clinical research and provide a theoretical basis to slow the development of DKD in patients.
Copyright © 2022 Qi, Hu, Zhao and Li.

Entities:  

Keywords:  biological function; diabetes kidney disease; pathological process; signaling pathway; sirtuins

Mesh:

Substances:

Year:  2022        PMID: 35634495      PMCID: PMC9136398          DOI: 10.3389/fendo.2022.801303

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   6.055


  149 in total

1.  The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats.

Authors:  Lina Wu; Yinghui Zhang; Xiaokun Ma; Na Zhang; Guijun Qin
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

2.  The anti-nephritic activity of a polysaccharide from okra (Abelmoschus esculentus (L.) Moench) via modulation of AMPK-Sirt1-PGC-1α signaling axis mediated anti-oxidative in type 2 diabetes model mice.

Authors:  Zhengzheng Liao; Jingying Zhang; Jinyu Wang; Tingxu Yan; Fanxing Xu; Bo Wu; Feng Xiao; Kaishun Bi; Jumin Niu; Ying Jia
Journal:  Int J Biol Macromol       Date:  2019-08-20       Impact factor: 6.953

3.  P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy.

Authors:  Fuzhe Ma; Junduo Wu; Ziping Jiang; Wenlin Huang; Ye Jia; Weixia Sun; Hao Wu
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-04-06       Impact factor: 4.739

4.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

5.  STC-1 ameliorates renal injury in diabetic nephropathy by inhibiting the expression of BNIP3 through the AMPK/SIRT3 pathway.

Authors:  Zhiwen Liu; Hong Liu; Li Xiao; Guoyong Liu; Lin Sun; Liyu He
Journal:  Lab Invest       Date:  2019-01-25       Impact factor: 5.662

Review 6.  Obesity, the PI3K/Akt signal pathway and colon cancer.

Authors:  X-F Huang; J-Z Chen
Journal:  Obes Rev       Date:  2009-06-12       Impact factor: 9.213

Review 7.  Association of genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus.

Authors:  Shania Abbas; Syed Tasleem Raza; Faisal Ahmed; Absar Ahmad; Saliha Rizvi; Farzana Mahdi
Journal:  J Biomed Sci       Date:  2013-10-25       Impact factor: 8.410

8.  Inhibition of miRNA‑135a‑5p ameliorates TGF‑β1‑induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy.

Authors:  Juan Zhang; Lian Zhang; Dongqing Zha; Xiaoyan Wu
Journal:  Int J Mol Med       Date:  2020-06-17       Impact factor: 4.101

9.  Protective Actions of Anserine Under Diabetic Conditions.

Authors:  Verena Peters; Vittorio Calabrese; Elisabete Forsberg; Nadine Volk; Thomas Fleming; Hans Baelde; Tim Weigand; Christian Thiel; Angela Trovato; Maria Scuto; Sergio Modafferi; Claus Peter Schmitt
Journal:  Int J Mol Sci       Date:  2018-09-13       Impact factor: 5.923

10.  Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-κB p65 axis.

Authors:  Xiaolei Wang; Yanbin Gao; Nianxiu Tian; Tao Wang; Yimin Shi; Jiayi Xu; Bingjie Wu
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.